<--- Back to Details
First PageDocument Content
Medicine / Gadopentetic acid / Gadolinium / Nephrogenic systemic fibrosis / Magnetic resonance imaging / Pentetic acid / Renal failure / Lorazepam / MRI contrast agent / Chemistry / Matter / Nephrology
Date: 2012-04-11 15:23:45
Medicine
Gadopentetic acid
Gadolinium
Nephrogenic systemic fibrosis
Magnetic resonance imaging
Pentetic acid
Renal failure
Lorazepam
MRI contrast agent
Chemistry
Matter
Nephrology

Magnevist injection label

Add to Reading List

Source URL: www.berlex.com

Download Document from Source Website

File Size: 147,32 KB

Share Document on Facebook

Similar Documents

Contrast enhancement in MR imaging: New options, new techniques, new opportunities Nephrogenic systemic fibrosis update 2014: Fact versus theory Emanuel Kanal, MD, FACR, FISMRM

DocID: 1g70b - View Document

Kidney diseases / Organ failure / Nephrogenic systemic fibrosis / Nephrology / Gadolinium / Magnetic resonance imaging / Acute kidney injury / MRI contrast agent / Gadodiamide / Medicine / Chemistry / Anatomy

[removed] ® HIGHLIGHTS OF PRESCRIBING INFORMATION

DocID: Wwpb - View Document

Gadolinium / Nephrogenic systemic fibrosis / Magnetic resonance imaging / MRI contrast agent / Flucytosine / Chemistry / Matter / Gadodiamide

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use OMNISCAN safely and effectively. See full prescribing information for OMNISCAN. OMNISCANTM (gadodiamide) Injection f

DocID: LwKY - View Document

Medicine / Nephrogenic systemic fibrosis / Organochlorides / Gadolinium / Magnetic resonance imaging / Renal failure / Lorazepam / Gadoversetamide / MRI contrast agent / Chemistry / Nephrology / Matter

OPTIMARK (gadoversetamide) injection Label

DocID: KSKv - View Document

Vaccines / Papillomavirus / Merck / Combination drugs / Merck & Co. / Gadolinium / Food and Drug Administration / Lisinopril / Nephrogenic systemic fibrosis / Chemistry / Pharmacology / Medicine

FDA Patient Safety News: Show #54, August 2006

DocID: HDJ2 - View Document